Hara I - Search Results

1

Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential.

Miyake H, Hara I, Yoshimura K, Eto H, Arakawa S, Wada S, Chihara K, Kamidono S. Miyake H, et al. Among authors: hara i. Cancer Res. 1996 May 15;56(10):2440-5. Cancer Res. 1996. PMID: 8625325

2

[Nephron sparing surgery of patients with renal cell carcinoma in a solitary kidney or bilateral renal cell carcinoma].

Etoh H, Ueno K, Miyake H, Sugiyama T, Oka Y, Hara I, Nakamura I, Okada H, Arakawa S, Kamidono S. Etoh H, et al. Among authors: hara i. Nihon Hinyokika Gakkai Zasshi. 1995 Jul;86(7):1255-60. doi: 10.5980/jpnjurol1989.86.1255. Nihon Hinyokika Gakkai Zasshi. 1995. PMID: 7637241 Free article. Japanese.

3

Messenger ribonucleic acids for fibroblast growth factors and their receptor in bladder and renal cell carcinoma cell lines.

Yoshimura K, Eto H, Miyake H, Hara I, Arakawa S, Kamidono S. Yoshimura K, et al. Among authors: hara i. Cancer Lett. 1996 May 15;103(1):91-7. doi: 10.1016/0304-3835(96)04198-5. Cancer Lett. 1996. PMID: 8616814

4

Rejection of mouse renal cell carcinoma elicited by local secretion of interleukin-2.

Hara I, Hotta H, Sato N, Eto H, Arakawa S, Kamidono S. Hara I, et al. Jpn J Cancer Res. 1996 Jul;87(7):724-9. doi: 10.1111/j.1349-7006.1996.tb00284.x. Jpn J Cancer Res. 1996. PMID: 8698622 Free PMC article.

5

Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines.

Miyake H, Yoshimura K, Hara I, Eto H, Arakawa S, Kamidono S. Miyake H, et al. Among authors: hara i. J Urol. 1997 Jun;157(6):2351-5. J Urol. 1997. PMID: 9146669

6

p53 modulation of Fas/Apo-1 mediated apoptosis in a human renal cell carcinoma cell line.

Miyake H, Hara I, Gohji K, Arakawa S, Kamidono S. Miyake H, et al. Among authors: hara i. Int J Oncol. 1998 Feb;12(2):469-73. doi: 10.3892/ijo.12.2.469. Int J Oncol. 1998. PMID: 9458377

7

Expression of basic fibroblast growth factor is associated with resistance to cisplatin in a human bladder cancer cell line.

Miyake H, Hara I, Gohji K, Yoshimura K, Arakawa S, Kamidono S. Miyake H, et al. Among authors: hara i. Cancer Lett. 1998 Jan 30;123(2):121-6. doi: 10.1016/s0304-3835(97)00365-0. Cancer Lett. 1998. PMID: 9489477

8

Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension.

Gohji K, Fujimoto N, Hara I, Fujii A, Gotoh A, Okada H, Arakawa S, Kitazawa S, Miyake H, Kamidono S, Nakajima M. Gohji K, et al. Among authors: hara i. Int J Cancer. 1998 Feb 20;79(1):96-101. doi: 10.1002/(sici)1097-0215(19980220)79:1<96::aid-ijc18>3.0.co;2-f. Int J Cancer. 1998. PMID: 9495366

9

Multifocal renal cell carcinoma in Japanese patients with tumors with maximal diameters of 50 mm. or less.

Gohji K, Hara I, Gotoh A, Eto H, Miyake H, Sugiyama T, Okada H, Arakawa S, Kamidono S. Gohji K, et al. Among authors: hara i. J Urol. 1998 Apr;159(4):1144-7. J Urol. 1998. PMID: 9507818

10

Influence of cytokines and growth factors on matrix metalloproteinase-2 production and invasion of human renal cancer.

Gohji K, Nomi M, Hara I, Arakawa S, Kamidono S. Gohji K, et al. Among authors: hara i. Urol Res. 1998;26(1):33-7. doi: 10.1007/s002400050020. Urol Res. 1998. PMID: 9537694

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

697 results

Search Page

Filters